Znanstveni rad - Izvorni znanstveni rad
Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms
Biomedicines, 11 (2023), 5; 1301. https://doi.org/10.3390/biomedicines11051301


Citirajte ovaj rad

Krečak, I., Pivac, Lj., Lucijanić, M. i Skelin, M. (2023). Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms. Biomedicines, 11. (5). doi: 10.3390/biomedicines11051301

Krečak, Ivan, et al. "Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms." Biomedicines, vol. 11, br. 5, 2023. https://doi.org/10.3390/biomedicines11051301

Krečak, Ivan, Ljerka Pivac, Marko Lucijanić i Marko Skelin. "Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms." Biomedicines 11, br. 5 (2023). https://doi.org/10.3390/biomedicines11051301

Krečak, I., et al. (2023) 'Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms', Biomedicines, 11(5). doi: 10.3390/biomedicines11051301

Krečak I, Pivac Lj, Lucijanić M, Skelin M. Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms. Biomedicines [Internet]. 27.04.2023. [pristupljeno 23.07.2024.];11(5). doi: 10.3390/biomedicines11051301

I. Krečak, Lj. Pivac, M. Lucijanić i M. Skelin, "Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms", Biomedicines, vol. 11, br. 5, Travanj 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:727819. [Citirano: 23.07.2024.]